These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10568650)

  • 1. Limiting infant exposure to thimerosal in vaccines and other sources of mercury.
    Halsey NA
    JAMA; 1999 Nov; 282(18):1763-6. PubMed ID: 10568650
    [No Abstract]   [Full Text] [Related]  

  • 2. An assessment of thimerosal use in childhood vaccines.
    Ball LK; Ball R; Pratt RD
    Pediatrics; 2001 May; 107(5):1147-54. PubMed ID: 11331700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service.
    Ann Pharmacother; 1999 Sep; 33(9):1021. PubMed ID: 10492513
    [No Abstract]   [Full Text] [Related]  

  • 4. Mercury rising: warnings in pregnancy & infancy.
    Ohm J
    Midwifery Today Int Midwife; 2005; (74):46-7, 68. PubMed ID: 16022361
    [No Abstract]   [Full Text] [Related]  

  • 5. Thimerosal in vaccines--An interim report to clinicians. American Academy of Pediatrics. Committee on Infectious Diseases and Committee on Environmental Health.
    Pediatrics; 1999 Sep; 104(3 Pt 1):570-4. PubMed ID: 10469789
    [No Abstract]   [Full Text] [Related]  

  • 6. What happened to primum non nocere?
    Seal JB; Daum RS
    Pediatrics; 2001 May; 107(5):1177-8. PubMed ID: 11331704
    [No Abstract]   [Full Text] [Related]  

  • 7. Mercury, vaccines, and autism, revisited.
    Silbergeld EK
    Am J Public Health; 2008 Aug; 98(8):1350; author reply 1350-1. PubMed ID: 18556596
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccines and autism: evidence does not support a causal association.
    DeStefano F
    Clin Pharmacol Ther; 2007 Dec; 82(6):756-9. PubMed ID: 17928818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mercury, vaccines, and autism: one controversy, three histories.
    Baker JP
    Am J Public Health; 2008 Feb; 98(2):244-53. PubMed ID: 18172138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does thimerosal or other mercury exposure increase the risk for autism? A review of current literature.
    Schultz ST
    Acta Neurobiol Exp (Wars); 2010; 70(2):187-95. PubMed ID: 20628442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants.
    Stajich GV; Lopez GP; Harry SW; Sexson WR
    J Pediatr; 2000 May; 136(5):679-81. PubMed ID: 10802503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergic contact dermatitis from mercury antiseptics and derivatives: study protocol of tolerance to intramuscular injections of thimerosal.
    Audicana MT; Muñoz D; del Pozo MD; Fernández E; Gastaminza G; Fernández de Corres L
    Am J Contact Dermat; 2002 Mar; 13(1):3-9. PubMed ID: 11887097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balancing risks and benefits: Primum non nocere is too simplistic.
    Halsey NA; Goldman L
    Pediatrics; 2001 Aug; 108(2):466-7. PubMed ID: 11483816
    [No Abstract]   [Full Text] [Related]  

  • 14. Joint statement of the American Academy of Pediatrics (AAP) and the United States Public Health Service (USPHS).
    Pediatrics; 1999 Sep; 104(3 Pt 1):568-9. PubMed ID: 10469788
    [No Abstract]   [Full Text] [Related]  

  • 15. Thimerosal and vaccines--a cautionary tale.
    Offit PA
    N Engl J Med; 2007 Sep; 357(13):1278-9. PubMed ID: 17898096
    [No Abstract]   [Full Text] [Related]  

  • 16. Thimerosal and autism?
    Nelson KB; Bauman ML
    Pediatrics; 2003 Mar; 111(3):674-9. PubMed ID: 12612255
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of the Joint Statement by the American Academy of Pediatrics/US Public Health Service on thimerosal in vaccines on hospital infant hepatitis B vaccination practices.
    Hurie MB; Saari TN; Davis JP
    Pediatrics; 2001 Apr; 107(4):755-8. PubMed ID: 11335754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of thimerosal from vaccines set as goal.
    Miller JL
    Am J Health Syst Pharm; 1999 Aug; 56(16):1589, 1593. PubMed ID: 10459378
    [No Abstract]   [Full Text] [Related]  

  • 19. Exposure to thimerosal in vaccines used in Canadian infant immunization programs, with respect to risk of neurodevelopmental disorders.
    Bigham M; Copes R; Srour L
    Can Commun Dis Rep; 2002 May; 28(9):69-80. PubMed ID: 12012653
    [No Abstract]   [Full Text] [Related]  

  • 20. Preventing harm from thimerosal in vaccines.
    Plotkin SA
    JAMA; 2000 Apr; 283(16):2104-5. PubMed ID: 10791499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.